Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) Covered Calls

Actinium Pharmaceuticals Inc is a biopharmaceutical company which develops drugs for treatment of cancer. It is a development stage company.

You can sell covered calls on Actinium Pharmaceuticals, Inc. (Delaware) to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ATNM (prices last updated Fri 4:16 PM ET):

Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
6.85 +0.18 6.79 7.52 347K - 0.2
Covered Calls For Actinium Pharmaceuticals, Inc. (Delaware) (ATNM)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 17 7.5 0.40 7.12 5.3% 66.7%
Jun 21 7.5 0.25 7.27 3.2% 18.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Actinium Pharmaceuticals, Inc. operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers. The company's targeted radiotherapy products are based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting actinium-225 and bismuth-213 and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. Its lead radiopharmaceutical Iomab-B will be used, upon approval, in preparing patients for hematopoietic stem cell transplant, commonly referred to as bone marrow transplant. The company was founded in 1993 and is headquartered in New York, NY.